期刊文献+

番茄红素和大豆异黄酮组合物的毒理学评价 被引量:3

Toxicology Assessment of Lycopene and Soybean Isoflavone Compound
下载PDF
导出
摘要 背景与目的:对番茄红素和大豆异黄酮组合物的食用安全性进行毒理学评价。材料与方法:根据《保健食品检验与评价技术规范》进行大鼠经口急性毒性试验、小鼠骨髓嗜多染红细胞微核试验、小鼠精子畸形试验、Ames试验。结果:番茄红素和大豆异黄酮组合物的大鼠经口LD50>10.0 g/kg;小鼠骨髓嗜多染红细胞微核试验、小鼠精子畸形试验及Ames试验结果均为阴性。结论:番茄红素和大豆异黄酮组合物属无毒级物质,无致突变作用。 BACKGROUND AND AIM: To evaluate the safety of the compound of lycopene and soybean isoflavone in order to provide some toxicological data for its application. MATERIALS AND METHODS: Acute toxicity test, bone marrow cell micronucleus test,mice sperm abnormality test,Ames test were conducted in accordance with the "Technical Standards for Testing & Assessment of Health Food" . RESULTS: Acute toxicity test of oral dosing showed LD50〉 10.0 g/kg in mice. Salmonella typhimurium/mammals mierosomal enzyme test and micronucleus test of bone marrow cells showed that the compound was safe without mutagenesis. No toxicity was observed in sperm shape abnormality test in mice. CONCLUSION: The compound of lycopene and soybean isoflavone is a non-toxic, non-mutagenic preparation.
出处 《癌变.畸变.突变》 CAS CSCD 2009年第4期313-315,319,共4页 Carcinogenesis,Teratogenesis & Mutagenesis
关键词 番茄红素 大豆异黄酮 急性毒性 致突变性 lycopene soybean isoflavone acute toxicity mutagenicity
  • 相关文献

参考文献10

二级参考文献61

  • 1黄玥,沈新南,刘艳妮,姚国英.番茄红素预防大鼠高血糖及其作用机制[J].营养学报,2006,28(3):244-246. 被引量:11
  • 2潘艺元,凌日云,陈全斌.文献计量分析揭示我国番茄红素研究现状[J].广西轻工业,2006,22(5):46-47. 被引量:3
  • 3[1]Boersma BJ,Patel RP,Kirk M,et al.Chlorination and nitration of soy isoflavones[J].Arch Biochem Biophys,1999,368:265.
  • 4[2]Adlercreutz H,Mazur W.Phyto-estrogens and western disease[J].Ann Med,1997,29:95.
  • 5[3]Chang HC,Churchewell MI,Delclos KB,et al.Mass spectrometric determination of genistein tissue distribution in diet-exposed Sprague-Dawley rats[J].J Nutr,2000,130:1963.
  • 6[4]Makela SI,Santti R,Salo L,et al.Phytoestrogens are partial estrogen agonists in the adult male mouse[J].Environ Health Perspect,1995,103:123.
  • 7[5]McDonnell DP,Norris JD.Analysis of the molecular pharmacology of estrogen receptor agonists and antagonists provides insights into the mechanism of action of estrogen in bone[J].Osteoporos Int,1997.7:S29.
  • 8[6]Kuiper GGJM,Carlsson B,Grandien K.Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β[J].Endocrinology,1997,138:863.
  • 9[7]Wei H,Bowen R,Cai Q,et al.Antioxidant and antipromotional effects of the soybean isoflavone genistein[J].Proc Soc Exp Biol Med,1995,208:124.
  • 10[8]Markowitz SD,Roberts AB.Tumor suppressor activity of the TGF-β pathway in human cancers[J].Cytokine Growth Factor Rev,1997,7:93.

共引文献67

同被引文献28

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部